Articles | Frontiers

Original Research

Published 1 July 2026

Pemafibrate is associated with greater reductions in MDA-LDL and small dense LDL fractions with exploratory PBMC gene-expression changes: a prespecified subanalysis of the PARADISE in Kagoshima study

Toru Kubo · Takahisa Deguchi · Kaori Matsuzaki · Atsushi Shinnakasu · Shigeru Kawade · Aiko Arimura · Hiroshi Hashiguchi · Kazuma Ogiso · Tetsuro Kamada · Mihoko Kurano · Katsutaro Morino · Yoshihiko Nishio

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2026.1850470